Clinical trial
Dendritic Cells in Lung Cancer
NCT00442754 · Herlev Hospital, Other · Completed
Key facts
| NCT number | NCT00442754 |
|---|---|
| Title | Dendritic Cells in Lung Cancer |
| Official title | Vaccination With Autologous Dendritic Cells Pulsed With Allogeneic Tumour Lysate (MelCancerVac) for the Treatment of Patients With Advanced or Metastatic Non-Small Cell Lung Cancer. A Phase II Study |
| Lead sponsor | Herlev Hospital, Other |
| Collaborators | University of Copenhagen |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Non Small Cell Lung Cancer |
| Intervention type | Biological |
| Interventions | Allogeneic Tumour Lysate (MelCancerVac) |
| Enrollment | 50 |
| Start date | Dec 1, 2006 |
| Primary completion | Nov 1, 2009 |
| Completion | Nov 1, 2009 |
| First posted | Mar 2, 2007 |
| Last update posted | Mar 20, 2012 |
| Countries | Denmark |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: